News
Innovent Biologics doses first participant in phase 3 clinical study of picankibart: San Francisco Friday, May 30, 2025, 12:00 Hrs [IST] Innovent Biologics, Inc, a world-class bio ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback